What it is
Kutaj names the plant (Holarrhena antidysenterica). Patients usually meet named products built from it: Kutajghan Vati, Kutajarishta, or bark preparations. Same plant, different products.
Practitioners choose among those preparations by clinical context. Patient memory usually stops at the bowel problem and the word kutaj.
Where you will encounter it
- Patients who say "my Ayurvedic doctor gave kutaj for IBS" without knowing whether that was vati, arishta, or bark
- Practitioner prescribing where bark, kutajghan vati, and kutajarishta are deliberate choices, not interchangeable labels
- OTC digestive shelves where kutajarishta bottles sit beside kutajghan vati strips under one kutaj search term
- Conversations that compare kutaj to Western antidiarrheals or probiotics as one stomach category
Further detail
Named preparations
The preparation is the medicine.
Kutajghan Vati, Kutajarishta, and bark decoction each have a place in classical atisara, pravahika, and grahani care. Practitioners choose among them. Hearing "kutaj" does not name which one arrived in the bottle.
What human research has studied
Evidence follows the named preparation, not the plant word.
Open-label work has studied kutajarishta directly in irritable bowel syndrome over weeks, reporting symptom score improvement and tolerability in large outpatient cohorts. Acute diarrhea trials and case series address kutajghan vati in atisara frameworks. Preclinical work on kutaj bark and kutajarishta reports motility and antisecretory signals in laboratory models.
A result on kutajarishta liquid does not license kutajghan vati at an unknown dose. Bark powder does not inherit arishta trial language. None substitutes for infectious diarrhea workup when fever or blood appears.
What the evidence does not justify
- Hearing kutaj and assuming kutajarishta, kutajghan vati, and bark powder share one evidence file
- Applying kutajarishta IBS trial results to kutajghan vati without reading the classical name on the bottle
- Treating any antidiarrheal OTC or probiotic as equivalent to a named classical kutaj product
- Using astringent kutaj formulations long term in constipation-predominant IBS without reassessment
- Delaying stool culture, celiac workup, or inflammatory bowel evaluation because kutaj helped briefly
Questions worth asking
The useful first question is "Which kutaj product?"
- Which exact product is on the label: kutajarishta liquid, kutajghan vati, or kutaj bark powder?
- Loose stools with blood, fever, weight loss, or travel history?
- IBS with constipation predominance, or diarrhea and urgency predominance?
- Alcohol content in arishta: driving, pregnancy, or liver disease context?
Safety and interaction attention
Safety follows the preparation.
Kutaj products carry stambhana (astringent) logic suited to excess loss, not every bowel pattern. Arishta preparations contain self-generated alcohol that deserves explicit counseling. Acute infectious diarrhea, pregnancy, and pediatric use need conventional assessment alongside any classical antidiarrheal.
Sources
- Anonymous. An open-label prospective study to assess the effectiveness, tolerability, and safety of Ayurvedic intervention (Kutajarishta) in the treatment of irritable bowel syndrome. J Natural Remedies. 2025. doi:10.18311/jnr/2025/36414
- Anonymous. Safety evaluation of Bilvadi Leha and Kutajarishta in the management of irritable bowel syndrome. J Res Ayurvedic Sci. 2017. doi:10.5005/jp-journals-10064-0015
- Bhat S, Ravishankar B. An experimental study of Kutajarishta for its action on intestinal motility. Int J Res Ayurveda Pharm. 2015. doi:10.7897/2277-4343.065115
Evidence blocks last reviewed: July 2026.